Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Growth 100%
• Mouse 100%
• Breast Tumor 100%
• Non Insulin Dependent Diabetes Mellitus 100%
• Breast Cancer 28%
• Cancer Mortality 28%
• Disease 14%
• Neoplasm 14%
• Tumor Model 14%
• Polyomavirus 14%
• Mouse Model 14%
• Adrenergic Receptor Stimulating Agent 14%
• Hyperinsulinemia 14%

Keyphrases

• Insulin Sensitizers 100%
• Tumor Model 20%
• Mouse Mammary Tumor 20%
• Early Administration 20%

Medicine and Dentistry

• Polyomavirus 16%